Voyager Pharmaceutical, a biopharmaceutical company developing drugs for diseases associated with aging and development, registered for an initial public offering Friday morning. WR Hambrecht will be the sole underwriter as the Raleigh, NC-based company plans to use a Dutch auction-style IPO to distribute shares. Terms and timing have yet to be released.
IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
